N: integer for the total sample size of the trial.
a: nonnegative parameter which controls the degree of randomness: For decreasing a the allocations become deterministic, while for increasing a the randomization procedure tends to complete randomization.
K: number of treatment groups (e.g. K=2 if we compare one experimental against one control treatment).
Returns
A vector with the allocation sequence for a clinical trial. It will contain a zero (resp. 1) at position i, when patient i
is allocated to treatment A (resp. B).
References
A. B. Antognini and Maroussa Zagoraiou (2014) Balance and randomness in sequential clinical trials: the dominant biased coin design. Pharmaceutical Statistics